SCHEMBL467367

SCHEMBL467367

CN(Cc1ccccc1)C1CCN(c2ccc(C#N)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.47
NOS3 P29474 2/20 0.47
NOS1 P29475 2/20 0.47
NOS2 P35228 2/20 0.47
CYP2D6 P10635 1/20 0.47
CHRM1 P11229 1/20 0.47
HRH1 P35367 1/20 0.47
SLC6A4 P31645 1/20 0.46
NAAA Q02083 1/20 0.45
RORC P51449 2/20 0.45
CHRM4 P08173 2/20 0.44
CHRNA10 Q9GZZ6 1/20 0.43
CHRNA9 Q9UGM1 1/20 0.43
CYP3A4 P08684 2/20 0.43
KDM4E B2RXH2 2/20 0.42
GRIN2B Q13224 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
KCNH2 Q12809 1/20 0.42
CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7339715 0.99 MCHR1 (0.47) MCHR1NOS3NOS1NOS2CYP2D6
SCHEMBL9451632 0.88 KDM4E (0.57) CYP2D6CHRM1HRH1CHRNA10CHRNA9
SCHEMBL14136358 0.84 DPP4 (0.43) MCHR1NOS3NOS1NOS2CYP2D6
SCHEMBL5543151 0.84 MCHR1 (0.48) MCHR1NOS3NOS1NOS2CYP2D6
SCHEMBL7310386 0.83 MCHR1 (0.50) MCHR1CYP2D6CHRM1HRH1RORC
SCHEMBL14183554 0.83 KCNJ1 (0.50) ALDH1A1KCNH2
SCHEMBL27629490 0.80 NPY5R (0.46) CHRM4CHRNA10CHRNA9CYP3A4KDM4E
SCHEMBL3956758 0.80 MCHR1 (0.61) MCHR1RORC
SCHEMBL7225036 0.79 KDM4E (0.53) HRH1CHRNA10CHRNA9CYP3A4KDM4E
SCHEMBL2776292 0.77 SLC6A2 (0.55) SLC6A4CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2600863-B1 USE OF SIGMA LIGANDS IN OPIOID-INDUCED HYPERALGESIA ESTEVE LABOR DR (ES) 2018-03-28 EP disclosed
EP-2646025-B1 USE OF SIGMA LIGANDS IN BONE CANCER PAIN ESTEVE LABOR DR (ES) 2017-03-15 EP disclosed
EP-2531191-B1 Sigma ligands for use in the prevention and/or treatment of postoperative pain ESTEVE LABOR DR (ES) 2016-03-30 EP disclosed
EP-2571501-B1 SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY ESTEVE LABOR DR (ES) 2016-03-02 EP disclosed
EP-2460519-A1 Use of sigma ligands in bone cancer pain Laboratorios Del. Dr. Esteve, S.A. (ES) 2012-06-06 EP disclosed
EP-2415471-A1 Use of sigma ligands in opioid-induced hyperalgesia Laboratorios Del. Dr. Esteve, S.A. (ES) 2012-02-08 EP disclosed
EP-2388005-A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-11-23 EP disclosed
EP-2353598-A1 Sigma ligands for use in the prevention and/or treatment of postoperative pain Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-08-10 EP disclosed